Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte replacement used to treat or prevent hypokalemia. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretics or corticosteroids. ## Adult Dosing * **Treatment of Hypokalemia:** Oral doses typically range from 20-60 mEq per day, divided into 2-4 doses. Intravenous doses vary significantly based on severity and serum potassium levels, but initial doses often range from 10-20 mEq administered over 1-2 hours. **Maximum infusion rates for IV potassium are critical to prevent cardiotoxicity and are typically limited to 10-20 mEq/hour, with higher rates (up to 40 mEq/hour) reserved for severe, life-threatening hypokalemia and continuous ECG monitoring.** Central venous access is preferred for concentrations >40 mEq/L. * **Prevention of Hypokalemia:** Oral doses typically range from 10-20 mEq per day. Specific dosing depends on serum potassium levels, clinical condition, and local institutional protocols. ## Pediatric Dosing * **Oral:** Recommended daily intake is generally 1-3 mEq/kg/day, not to exceed adult maximums. Doses should be individualized. * **Intravenous:** Dosing is highly individualized based on serum potassium and clinical status. **Maximum concentration for peripheral IV infusion is generally 40 mEq/L and maximum infusion rate is 0.3-0.5 mEq/kg/hour (or 20 mEq/hour), not to exceed 20-40 mEq/hour in critical situations with continuous monitoring.** Central venous access allows for higher concentrations (up to 80-100 mEq/L) and potentially faster rates in urgent situations. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium is renally excreted; impaired renal function can lead to hyperkalemia. Dose reduction or avoidance may be necessary. ## Contraindications * Hyperkalemia. * Conditions which may predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, rapid dehydration, extensive tissue breakdown). * Patients receiving potassium-sparing diuretics concurrently, unless hypokalemia is severe and other measures are ineffective. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort (oral). * **Serious:** Hyperkalemia (symptoms include muscle weakness, paresthesias, paralysis, cardiac arrhythmias, cardiac arrest), venous irritation or phlebitis (IV), cardiac arrest (with rapid IV infusion). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors, Angiotensin II Receptor Blockers (ARBs), NSAIDs, Heparin, Trimethoprim:** Can increase serum potassium, increasing the risk of hyperkalemia. * **Aldosterone antagonists:** Increased risk of hyperkalemia. * **Beta-blockers:** May potentiate the effect of potassium on hyperkalemia. * **Digitalis glycosides:** Hyperkalemia can potentiate digitalis toxicity; hypokalemia can increase digitalis toxicity. ## Monitoring * **Serum potassium levels:** Frequently monitor, especially during IV therapy or with dose changes. * **Renal function (BUN, creatinine):** Essential due to risk of hyperkalemia in renal impairment. * **ECG:** Especially with IV potassium administration, particularly at higher rates or concentrations, to detect signs of hyperkalemia (e.g., peaked T waves, widened QRS). * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride has a distinct, unpleasant taste; mixing with sufficient fluid (e.g., juice, water) can improve palatability and reduce gastrointestinal upset. * **Never administer IV potassium chloride as an undiluted bolus.** * The risk of hyperkalemia is increased in patients with acidosis, renal insufficiency, or concurrent use of other potassium-increasing agents. * Always confirm the formulation and concentration of IV potassium chloride before administration. This information is intended as a reference and does not replace a thorough review of the most current prescribing information. Always verify current prescribing information with the manufacturer or a reliable drug reference.